Kyverna Therapeutics Names Cell Therapy Expert Tom Van Blarcom, Ph.D., as Senior Vice President, Head of Research

/PRNewswire/ -- Kyverna Therapeutics ("Kyverna"), a cell therapy company engineering a new class of therapies for serious autoimmune diseases, today announced...

Related Keywords

Texas ,United States ,Tom Van Blarcom ,Kyverna Treg ,Jeffrey Greve ,Dominic Borie ,Van Blarcom ,Amgen ,Pfizer ,University Of Texas At Austin ,Head Of Research ,Protein Engineering Department ,Carolina State University ,Research Operation ,Senior Vice President ,Chief Scientific Officer ,Allogene Therapeutics ,Executive Director ,Protein Engineering ,North Carolina State ,Kyverna Therapeutics ,